ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
De-ursil RR Mite 225 mg, Hartkapseln, retardiert - 20
44619008 Cheplapharm Schweiz GmbH
De-ursil RR Mite 225 mg, Hartkapseln, retardiert28.06.1983
  28.06.1983
Ursodeoxycholic Acid (A05AA02)02.10.2007
WHO-DDD 
04.99.20
04.99. 
B  
Yes 
IPCI
16.92Yes
    
10 %34.80
7680446190089Synthetika
 ● 
Composition
acidum ursodeoxycholicum 225 mg, talcum, cellulosum microcristallinum, carmellosum natricum conexum, carmellosum natricum, E 218 0.09 mg, gelatina, sorbitolum 1.41 mg, povidonum K 90, magnesii stearas, Überzug: acidi methacrylici et methylis methacrylatis polymerisatum 1:1, tributylis citras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, macrogolum 6000, E 171, E 172 (rubrum), talcum, Kapselhülle: gelatina, pro capsula corresp. natrium 0.33 mg.
Packungsbestandteile
Capsules 
  
 
Active AgentDose
Ursodeoxycholic Acid225 mg
BAG: Active AgentDose
Ursodeoxycholic Acid225 mg
 
Inactive agentsDoseadditional_information
(Rubrum)  
Acidi Methacrylici  
Carmellose Sodium  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
E 2180.09 mgconserv.
Ethylis Acrylatis Polymerisatum  
Gelatina  
Macrogol6000  
Magnesii Stearas  
Methylis Methacrylatis Polymerisatum  
Povidonum K90  
Sorbitol1.41 mg 
Talcum  
Tributylis Citras  
 
Source
Data was imported : 04.04.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home